Select Medical Holdings Corporation (SEM)
USD 18.28
(-4.39%)
USD 18.28
(-4.39%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 763.61 Million USD | 26.58% |
| 2022 | 585.3 Million USD | -34.23% |
| 2021 | 772.71 Million USD | 20.36% |
| 2020 | 683.3 Million USD | 13.15% |
| 2019 | 684.45 Million USD | 9.17% |
| 2018 | 621.82 Million USD | 5.43% |
| 2017 | 517.17 Million USD | 6.85% |
| 2016 | 448.39 Million USD | 18.79% |
| 2015 | 384.48 Million USD | 20.06% |
| 2014 | 352.83 Million USD | -0.31% |
| 2013 | 365.82 Million USD | -9.22% |
| 2012 | 401.81 Million USD | 15.94% |
| 2011 | 354.46 Million USD | 26.37% |
| 2010 | 305.03 Million USD | -0.95% |
| 2009 | 319.5 Million USD | 14.63% |
| 2008 | 269.57 Million USD | 6.16% |
| 2007 | 253.11 Million USD | -17.24% |
| 2006 | 305.77 Million USD | 85.99% |
| 2005 | 164.4 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 1.55 Billion USD | 4.31% |
| 2024 Q1 | 245.75 Million USD | 52.53% |
| 2024 Q2 | 211.91 Million USD | -18.01% |
| 2023 Q1 | 212.43 Million USD | 45.64% |
| 2023 Q4 | 178.43 Million USD | -87.75% |
| 2023 Q3 | 1.45 Billion USD | 562.96% |
| 2023 Q2 | 219.64 Million USD | 3.39% |
| 2023 FY | - USD | 26.58% |
| 2022 FY | - USD | -34.23% |
| 2022 Q3 | 151.01 Million USD | -15.27% |
| 2022 Q1 | 160.42 Million USD | 13.51% |
| 2022 Q2 | 178.21 Million USD | 11.09% |
| 2022 Q4 | 145.86 Million USD | -3.4% |
| 2021 Q4 | 141.33 Million USD | -33.28% |
| 2021 Q2 | 346.73 Million USD | 30.2% |
| 2021 Q1 | 266.3 Million USD | 18.56% |
| 2021 Q3 | 211.83 Million USD | -38.91% |
| 2021 FY | - USD | 20.36% |
| 2020 Q2 | 180.11 Million USD | -1.59% |
| 2020 Q4 | 224.61 Million USD | 4.47% |
| 2020 FY | - USD | 13.15% |
| 2020 Q1 | 183.01 Million USD | 6.93% |
| 2020 Q3 | 215 Million USD | 19.37% |
| 2019 Q4 | 171.15 Million USD | -6.37% |
| 2019 FY | - USD | 9.17% |
| 2019 Q2 | 187.26 Million USD | 7.16% |
| 2019 Q3 | 182.79 Million USD | -2.39% |
| 2019 Q1 | 174.76 Million USD | 18.16% |
| 2018 Q3 | 157.93 Million USD | -13.95% |
| 2018 Q2 | 183.54 Million USD | 14.39% |
| 2018 Q1 | 160.46 Million USD | 12.59% |
| 2018 FY | - USD | 5.43% |
| 2018 Q4 | 147.9 Million USD | -6.35% |
| 2017 Q4 | 142.52 Million USD | 5.09% |
| 2017 Q3 | 135.62 Million USD | -23.74% |
| 2017 Q2 | 177.83 Million USD | 10.87% |
| 2017 Q1 | 160.4 Million USD | 31.79% |
| 2017 FY | - USD | 6.85% |
| 2016 FY | - USD | 18.79% |
| 2016 Q1 | 167.66 Million USD | 43.59% |
| 2016 Q4 | 121.7 Million USD | 5.46% |
| 2016 Q3 | 115.4 Million USD | -33.11% |
| 2016 Q2 | 172.52 Million USD | 2.9% |
| 2015 Q2 | 122.99 Million USD | 9.94% |
| 2015 Q4 | 116.76 Million USD | -12.84% |
| 2015 Q3 | 133.96 Million USD | 8.92% |
| 2015 Q1 | 111.87 Million USD | 24.05% |
| 2015 FY | - USD | 20.06% |
| 2014 Q4 | 90.18 Million USD | -6.0% |
| 2014 FY | - USD | -0.31% |
| 2014 Q3 | 95.94 Million USD | -14.14% |
| 2014 Q2 | 111.74 Million USD | 4.83% |
| 2014 Q1 | 106.59 Million USD | 11.29% |
| 2013 Q2 | 113.58 Million USD | 4.48% |
| 2013 Q1 | 108.71 Million USD | -20.91% |
| 2013 FY | - USD | -9.22% |
| 2013 Q4 | 95.78 Million USD | 9.29% |
| 2013 Q3 | 87.64 Million USD | -22.84% |
| 2012 Q3 | 87.52 Million USD | -21.64% |
| 2012 Q1 | 110.26 Million USD | 16.85% |
| 2012 Q2 | 111.69 Million USD | 1.29% |
| 2012 Q4 | 137.44 Million USD | 57.04% |
| 2012 FY | - USD | 15.94% |
| 2011 FY | - USD | 26.37% |
| 2011 Q2 | 98.88 Million USD | -5.68% |
| 2011 Q1 | 104.83 Million USD | 58.66% |
| 2011 Q4 | 94.36 Million USD | 7.99% |
| 2011 Q3 | 87.39 Million USD | -11.62% |
| 2010 Q4 | 66.07 Million USD | 12.41% |
| 2010 FY | - USD | -0.95% |
| 2010 Q1 | 90.36 Million USD | 3.19% |
| 2010 Q2 | 89.18 Million USD | -1.3% |
| 2010 Q3 | 58.78 Million USD | -34.09% |
| 2009 FY | - USD | 14.63% |
| 2009 Q2 | 83.35 Million USD | -2.86% |
| 2009 Q1 | 85.8 Million USD | 12.47% |
| 2009 Q3 | 51.82 Million USD | -37.83% |
| 2009 Q4 | 87.56 Million USD | 68.97% |
| 2008 FY | - USD | 6.16% |
| 2008 Q1 | 72.22 Million USD | 26.02% |
| 2008 Q4 | 76.29 Million USD | 38.21% |
| 2008 Q3 | 55.2 Million USD | -16.88% |
| 2008 Q2 | 66.4 Million USD | -8.05% |
| 2007 Q2 | 74.89 Million USD | 2.67% |
| 2007 Q3 | 46.57 Million USD | -37.82% |
| 2007 Q4 | 57.31 Million USD | 23.05% |
| 2007 FY | - USD | -17.24% |
| 2007 Q1 | 72.95 Million USD | 2.21% |
| 2006 Q3 | 66.95 Million USD | -25.45% |
| 2006 Q2 | 89.81 Million USD | 15.69% |
| 2006 Q1 | 77.63 Million USD | 0.0% |
| 2006 Q4 | 71.37 Million USD | 6.6% |
| 2006 FY | - USD | 85.99% |
| 2005 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| agilon health, inc. | -167.64 Million USD | 555.501% |
| AMN Healthcare Services, Inc. | 499.35 Million USD | -52.92% |
| ATI Physical Therapy, Inc. | 82.86 Million USD | -821.496% |
| Brookdale Senior Living Inc. | 369.29 Million USD | -106.778% |
| Chemed Corporation | 403.69 Million USD | -89.157% |
| Community Health Systems, Inc. | 1.54 Billion USD | 50.543% |
| DaVita Inc. | 2.34 Billion USD | 67.456% |
| Enhabit, Inc. | -16.5 Million USD | 4727.976% |
| Encompass Health Corporation | 1 Billion USD | 24.071% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 93.997% |
| Pediatrix Medical Group, Inc. | 29.88 Million USD | -2455.011% |
| Sonida Senior Living, Inc. | 21.72 Million USD | -3415.566% |
| Solventum Corporation | 2.24 Billion USD | 66.046% |
| Tenet Healthcare Corporation | 3.65 Billion USD | 79.13% |
| Universal Health Services, Inc. | 1.74 Billion USD | 56.2% |
| U.S. Physical Therapy, Inc. | 74.37 Million USD | -926.724% |